Wang T, Dong Y, Huang Z et al
Clinical trials demonstrate that the co-administration of cagrilintide with semaglutide leads to significant reductions in HbA1c and body weight, highlighting their combined efficacy in managing obesity and metabolic disorders
Treatment response depends on deficiency severity, route of administration, underlying cause, patient age, concurrent medical conditions, and medication interactions
Learn More About PUUR Health and Wellness Here Resources:
Many patients who have both functional issues, such as looseness and urinary incontinence, in addition to a lack of sensitivity, will choose to have both the female sex injection and either ThermiVa or Exilis Ultra Femme